GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cryomass Technologies Inc (OTCPK:CRYM) » Definitions » Equity-to-Asset

Cryomass Technologies (Cryomass Technologies) Equity-to-Asset : -3.19 (As of Sep. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Cryomass Technologies Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cryomass Technologies's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $-3.42 Mil. Cryomass Technologies's Total Assets for the quarter that ended in Sep. 2023 was $1.07 Mil.

The historical rank and industry rank for Cryomass Technologies's Equity-to-Asset or its related term are showing as below:

CRYM' s Equity-to-Asset Range Over the Past 10 Years
Min: -3.19   Med: 0.58   Max: 0.95
Current: -3.19

During the past 12 years, the highest Equity to Asset Ratio of Cryomass Technologies was 0.95. The lowest was -3.19. And the median was 0.58.

CRYM's Equity-to-Asset is ranked worse than
96.22% of 1085 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs CRYM: -3.19

Cryomass Technologies Equity-to-Asset Historical Data

The historical data trend for Cryomass Technologies's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryomass Technologies Equity-to-Asset Chart

Cryomass Technologies Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.92 0.83 0.46 0.87 0.58

Cryomass Technologies Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.58 0.48 -2.03 -3.19

Competitive Comparison of Cryomass Technologies's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Cryomass Technologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryomass Technologies's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cryomass Technologies's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cryomass Technologies's Equity-to-Asset falls into.



Cryomass Technologies Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cryomass Technologies's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )=Total Stockholders Equity/Total Assets
=4.574/7.863
=

Cryomass Technologies's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )=Total Stockholders Equity/Total Assets
=-3.418/1.072
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cryomass Technologies  (OTCPK:CRYM) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Cryomass Technologies Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cryomass Technologies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryomass Technologies (Cryomass Technologies) Business Description

Traded in Other Exchanges
N/A
Address
1001 Bannock Street, Suite 612, Denver, CO, USA, 80204
Cryomass Technologies Inc designs, manufactures, and licenses field-mobile equipment for the handling of harvested cannabis, hemp, and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect and protect the high-value compounds from the harvested plant. The company's offerings include refinement systems and monitoring and control systems.
Executives
Philip Blair Mullin officer: Chief Financial Officer 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Christian Noel director, officer: Chief Executive Officer 3531 SOUTH LOGAN ST. SUITE D-357, ENGLEWOOD CO 80113
Patricia Izabel Kovacevic officer: GC, Corp Secy, and Head of EA 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Delon Hannes Human director 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mark Radke director 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mario Gobbo director 3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113